COO as reported
Cooper Companies (The) reported $4.23B of revenue over the trailing twelve months, +6.1% on the year before. 11 reported series are charted on this page, each one as filed.
$4.23B
Revenue, trailing twelve months · to Q2 2026 · +6.1% against the twelve months before
- Net Income
- $236M
Net Income · −43% year on year · trailing twelve months to Q2 2026
- Free Cash Flow
- $570M
Free Cash Flow · +56% year on year · trailing twelve months to Q2 2026
- Op Margin
- 12%
Op Margin · trailing twelve months to Q2 2026
| Series | Latest | Year on year | As of |
|---|---|---|---|
| Revenue | $4.23B | +6.1% | Q2 2026 |
| Net Income | $236M | −43% | Q2 2026 |
| EPS | $1.17 | −43% | Q2 2026 |
| Gross Margin | 66% | n/a | Q2 2026 |
| Op Margin | 12% | n/a | Q2 2026 |
| Net Margin | 5.7% | n/a | Q2 2026 |
| ROE | 4.3% | n/a | Q2 2026 |
| ROA | 2.9% | n/a | Q2 2026 |
| ROIC | 4.7% | n/a | Q2 2026 |
| Free Cash Flow | $570M | +56% | Q2 2026 |
| P/E | 62.1 | n/a | today |
Every figure straight from the statements as filed with the SEC, no scoring, no adjustment. Open a series for its full history.
Cooper Companies (The) (COO) - Revenue & ProfitRevenue & ProfitCooper Companies (The) (COO)
Revenue (TTM)Net Income (TTM)
Powered byryufin.com
Medical Instruments & Supplies
Ranks #19 of 27 by Smart Score